Lincoln Pharmaceuticals Limited (BOM:531633)

Market Cap	9.08B
Revenue (ttm)	6.32B
Net Income (ttm)	800.04M
Shares Out	20.03M
EPS (ttm)	39.94
PE Ratio	11.35
Forward PE	n/a
Dividend	1.80 (0.39%)
Ex-Dividend Date	Sep 12, 2025

Volume	1,340
Average Volume	719
Open	465.95
Previous Close	465.65
Day's Range	454.55 - 465.95
52-Week Range	461.50 - 819.95
Beta	0.16
RSI	35.38
Earnings Date	Feb 12, 2026

About Lincoln Pharmaceuticals

Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India. The company offers products in the areas of anticold, antibiotic, otolaryngology, pain management, gastro, anti-malarial, anti-fungal, corticosteroids and cosmo-derma, anti-diabetic, anti-hypertensive, gynecology, cardio and CNS, respiratory system, and dyslipidemic; and branded generics. It also exports its products to approximately 60 countries, including Europe, Canada, Latin and North America, Africa, the Asia Pacific, and South East As...

• Industry: Pharmaceutical Preparations
• Founded: 1979
• Employees: 1,853
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 531633

Financial Performance

In 2024, Lincoln Pharmaceuticals's revenue was 6.23 billion, an increase of 7.35% compared to the previous year's 5.81 billion. Earnings were 823.46 million, a decrease of -11.74%.